{
    "clinical_study": {
        "@rank": "116040", 
        "brief_summary": {
            "textblock": "A Phase III study to determine the sensitivity and specificity of three solutions of\n      different allergen extracts for diagnosis by skin prick-test:\n\n        -  5 Grasses pollen,\n\n        -  Birch pollen,\n\n        -  Dermatophagoides pteronyssinus mite"
        }, 
        "brief_title": "Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing", 
        "completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "condition": "Allergy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Written informed consent to participate in the study\n\n          -  Male or female subjects aged 5-60 years inclusive\n\n          -  Female of childbearing potential must be on a reliable method of contraception and\n             have a negative urine pregnancy test\n\n          -  Presence of a clinical history of allergy: seasonal or perennial rhinitis,\n             conjunctivitis and/or  asthma during grass or birch pollen seasons (at least two\n             pollen seasons) and/or due to mite exposure (at least two years)\n\n          -  Subjects affiliated to a social security system\n\n        Exclusion Criteria:\n\n          -  Pregnant or breastfeeding women\n\n          -  Dermographism\n\n          -  Absence of cutaneous reactivity\n\n          -  Presence of cutaneous lesions on the forearms either preventing the performance of\n             the test or potentially interfering with the interpretation of the test\n\n          -  Subjects presenting unstable asthma or poor general health condition\n\n          -  Subjects with past or current specific immunotherapy treatment for any of the 3\n             tested allergens (Grass, Birch pollens, D. pteronyssinus and/or D. farinae mites) in\n             the previous 5 years\n\n          -  Any oral antihistaminic treatment in the previous 3 days or 10 days in case of\n             loratadine or desloratadine\n\n          -  Subjects on anti-IgE treatment\n\n          -  Subjects treated with beta-blockers and/or anti-depressives.\n\n          -  Subjects currently participating in another clinical trial or still in exclusion\n             period for a previous clinical trial\n\n          -  Investigators, co-investigators, as well as their children or spouses and all the\n             study collaborators\n\n          -  Subjects under protection of the courts, legal guardianship or legal trusteeship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "324", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01964768", 
            "org_study_id": "DG40.08"
        }, 
        "intervention": {
            "intervention_name": "Skin prick-test", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 14, 2013", 
        "official_title": "Determination of Sensitivity and Specificity of Three Solutions of Allergen Extract (5 Grasses, Birch Pollens and Dermatophagoides Pteronyssinus Mites) for Diagnosis by Skin Prick Testing", 
        "other_outcome": {
            "measure": "The secondary measurement was also the specific IgE level for each allergen.", 
            "safety_issue": "Yes", 
            "time_frame": "Specific IgE results were known after the study visit, an expected average of 3 days."
        }, 
        "overall_official": {
            "affiliation": "H\u00f4pitaux Universitaires de Strasbourg, Nouvel H\u00f4pital Civil, Strasbourg, France", 
            "last_name": "Fr\u00e9d\u00e9ric de Blay, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Skin wheal measure for each tested solution. For each allergen tested, 2 variables, positive SPT and negative SPT were defined. A SPT reaction was considered positive when the mean wheal diameter was >3 mm. A SPT reaction \u22643 mm was considered negative.", 
            "safety_issue": "Yes", 
            "time_frame": "For each subject, the study consisted in one visit of about 60 minutes including skin prick-test and collection of blood sample for IgE determination."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01964768"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "One of the secondary measurement was the wheal diameter for each allergen.", 
            "safety_issue": "Yes", 
            "time_frame": "SPT measurements were performed after the study visit, an expected average of 1 week."
        }, 
        "source": "Stallergenes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stallergenes", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}